RYDAPT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug RYDAPT contains one active pharmaceutical ingredient (API):

1	Midostaurin UNII ID912S5VON - MIDOSTAURIN
	Midostaurin inhibits multiple receptor tyrosine kinases, including FLT3 and KIT kinase. Midostaurin inhibits FLT3 receptor signalling and induces cell cycle arrest and apoptosis in leukaemic cells expressing FLT3 ITD or TKD mutant receptors or over-expressing FLT3 wild type receptors.
	Read more about Midostaurin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RYDAPT Soft capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01EX10		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11505M, 11506N, 11518F, 11531X, 11552B, 11553C
BR	Câmara de Regulação do Mercado de Medicamentos	526518080094101
EE	Ravimiamet	1753769, 1764794
ES	Centro de información online de medicamentos de la AEMPS	1171218001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	500476, 519755
FR	Base de données publique des médicaments	67868413
GB	Medicines & Healthcare Products Regulatory Agency	353634
HK	Department of Health Drug Office	65725
IE	Health Products Regulatory Authority	89103
IL	מִשְׂרַד הַבְּרִיאוּת	8106, 8107
IT	Agenzia del Farmaco	045612013, 045612025
LT	Valstybinė vaistų kontrolės tarnyba	1083947, 1084937
NL	Z-Index G-Standaard, PRK	148016
NZ	Medicines and Medical Devices Safety Authority	20639
PL	Rejestru Produktów Leczniczych	100392385
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64447001
SG	Health Sciences Authority	15518P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504190151
US	FDA, National Drug Code	0078-0698